The Neurovascular Devices Market encompasses a range of medical devices designed for diagnosing and treating conditions affecting the blood vessels in the brain and spinal cord. These devices play a critical role in managing neurovascular disorders such as stroke, aneurysms, and arteriovenous malformations (AVMs). They include embolization coils, stents, neurothrombectomy devices, and flow diverters, among others, each serving specific functions in neurovascular interventions.

The global neurovascular devices market is estimated to be valued at US$ 2.64 Bn in 2023 and is expected to exhibit a CAGR of 4.1% during the forecast period (2023-2030).

Market Drivers

The growth of the Neurovascular Devices Market is propelled by several key drivers. One significant factor is the increasing prevalence of Neurovascular Devices Market diseases worldwide, fueled by factors like aging populations, sedentary lifestyles, and rising incidences of risk factors such as hypertension and diabetes. Technological advancements, including minimally invasive procedures and advanced imaging techniques, also contribute to market expansion by improving treatment outcomes and patient recovery times.